Back to results
US 2018/0021301 A1Published application
Aerosol formulation for copd
AssigneeChiesi Farmaceutici S.p.A.
InventorsSauro Bonelli, Francesca Usberti, Enrico Zambelli
Life of this patent
Estimating the term…
Abstract
The stable aerosol solution formulations comprising glycopyrronium chloride are useful for administration to patients with COPD and other respiratory conditions.
Claims17
A pharmaceutical composition, comprising glycopyrronium chloride dissolved in an HFA propellant and optionally a co-solvent, wherein said composition comprises an amount of acid equivalent to 0.05 to 0.4 μg/μ1 of 1M HCl.
Dependencies are inferred from the claim text.